Quantifying progression in multiple sclerosis: serum glial fibrillary acidic protein for personalised medicine and identification of novel targets
Research Project | 01.01.2023 - 31.12.2026
|
01.01.2023
- 31.12.2026
Funding
Quantifying progression in multiple sclerosis: serum glial fibrillary acidic protein (sGFAP) for personalised medicine and identification of novel targets
Schweizerischer Nationalfonds, 01.2023-12.2026 (48)
PI : Kuhle, Jens.
Members (1)
